,

,
,||
* Department of Pediatrics, Harvard Medical School, Boston, Massachusetts
Center for Adolescent Substance Abuse Research, Childrens Hospital, Boston, Massachusetts
Division of General Pediatrics, Childrens Hospital, Boston, Massachusetts
|| Division of Adolescent/Young Adult Medicine, Childrens Hospital, Boston, Massachusetts
Objective. To review home drug-testing products and the Internet-based recommendations intended for parents.
Methods. A qualitative review of drug-testing products and structured analysis of information presented on company Internet sites were conducted. Eight Internet sites that sold home drug-testing products and contained a "parents section" were identified by Ixquick using the search term "home drug testing." Description and prices of products sold by each Internet site and recommended indications for testing, consent, collection procedures, and follow-up of positive and negative test results were researched.
Results. A variety of drug-testing products were available, including breath and saliva tests for alcohol, a multidrug panel hair test, and a variety of laboratory and instant urine tests. Prices ranged from $2.75 for a single alcohol test to $89.00 for a multidrug combination urine/hair package. A total of 14 indications for home drug-testing were cited; all sites claimed that drug testing was a way to know with certainty whether a child has used drugs. Only 1 web site made a clear statement against testing an adolescent against his or her will. Little information was presented on valid specimen collection procedures and the risks of false-positive and false-negative tests. Only half of the sites recommended that parents consult a professional if a test is positive.
Conclusions. Pediatricians should advise parents of the limitations and potential risks associated with home drug-testing products.
Key Words: substance abuse detection substance related disorders adolescence
Abbreviations: MTF, Monitoring the Future FDA, Food and Drug Administration AAP, American Academy of Pediatrics PCP, phencyclidine MDMA, 3,4-methylinedioxymethamphetamine LSD, lysergic acid NIDA, National Institute on Drug Abuse
This article has been cited by other articles:
![]() |
L. A TABAK Point-of-Care Diagnostics Enter the Mouth Ann. N.Y. Acad. Sci., March 1, 2007; 1098(1): 7 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
Committee on Substance Abuse and Council on School Testing for Drugs of Abuse in Children and Adolescents: Addendum--Testing in Schools and at Home Pediatrics, March 1, 2007; 119(3): 627 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Levy, S. K. Harris, L. Sherritt, M. Angulo, and J. R. Knight Laboratory Testing for Drug Abuse--Reply Arch Pediatr Adolesc Med, August 1, 2006; 160(8): 854 - 854. [Full Text] [PDF] |
||||
![]() |
S. Levy, S. K. Harris, L. Sherritt, M. Angulo, and J. R. Knight Drug Testing of Adolescents in Ambulatory Medicine: Physician Practices and Knowledge Arch Pediatr Adolesc Med, February 1, 2006; 160(2): 146 - 150. [Abstract] [Full Text] [PDF] |
||||